Tolksdorf W, Prag H, Vorwold M, Amberger M
Klinik für Anästhesiologie, Medizinische Fakultät, RWTH Aachen.
Anaesthesist. 1992 Jul;41(7):391-5.
Whereas the efficacy of flumazenil (Fl) for improving vigilance in the presence of other benzodiazepine agonists (BZA) is undoubted, its effect on BZA- and/or opioid agonists (OA)-induced respiratory depression is the subject of controversies. Some authors describe an improvement of a midazolam (Mi)-induced increase in paCO2, whereas others cannot find any influence on diazepam-induced respiratory depression. In two studies in which Fl was used to antagonize Mi/Fentanyl (Fe) anaesthesia we found even worse oxygen saturation values than with placebo (Pl). All our previous studies indicate a slight intrinsic activity of Fl on respiration in the presence of opioids. We therefore investigated the influence of Fl and Pl on expiratory pCO2 and oxygen saturation (SAT). METHODS. A group of 15 male, healthy volunteers aged 20-30 years gave written informed consent to participate in this double blind study, which was approved by our Institutional Review Board. Each subject received 3 micrograms/kg body wt. Fe + 0.5 mg Fl and 1 week later 3 micrograms/kg body wt. Fe + 5 ml NaCl 0.9% (Pl) i.v., in random order. They were undisturbed and breathed spontaneously. The following parameters were measured: SAT, pCO2 and heart rate (HR) continuously, using a pulse oximeter (SAT, H) and CO2 infrared absorption monitor (Oscar, Messrs., Datex). The blood pressure was recorded before and after a 5-min preinjection period (baseline) and at the end of the procedure (25 min). The data were stored in a microcomputer (Multitalent, Messrs. ZAK) and transmitted to a PC after each trial. STATISTICS. The groups were compared with the Wilcoxon rank sum test. P less than 0.05 is significant. RESULTS. In trials 1 and 2 there was an increase of pCO2 and a drop in SAT. The changes in pCO2 and SAT were more pronounced after Fe+Fl in 12 subjects (80%), as against 1 subject with the opposite result. There were 2 subjects who showed no difference between trials 1 and 2. The combination of Fe and Fl caused significantly higher increases in pCO2 (P = 0.007) and more pronounced decreases in SAT (P = 0.04) than Fe and Pl. DISCUSSION. These results indicate a slight enhancement of Fe-induced respiratory depression by Fl. In a previous study it could be shown that Fl antagonized the respiratory depressive effect of Mi, but baseline paCO2 was not completely recovered. In previous studies respiratory function impaired by Mi+Fe was initially improved by Fl, but rebound effects on SAT were observed, which were more pronounced than those after Pl. Therefore, respiratory function must be closely monitored in Fl-antagonized patients after Mi/Fe anaesthesia.
尽管氟马西尼(Fl)在其他苯二氮䓬类激动剂(BZA)存在的情况下提高警觉性的功效是毋庸置疑的,但其对BZA和/或阿片类激动剂(OA)引起的呼吸抑制的影响仍存在争议。一些作者描述氟马西尼可改善咪达唑仑(Mi)引起的动脉血二氧化碳分压(paCO2)升高,而另一些作者则未发现其对地西泮引起的呼吸抑制有任何影响。在两项使用氟马西尼拮抗Mi/芬太尼(Fe)麻醉的研究中,我们发现与使用安慰剂(Pl)相比,氧饱和度值甚至更低。我们之前所有的研究均表明,在存在阿片类药物的情况下,氟马西尼对呼吸有轻微的内在活性。因此,我们研究了氟马西尼和安慰剂对呼气末pCO2和氧饱和度(SAT)的影响。方法。一组15名年龄在20 - 30岁的健康男性志愿者书面知情同意参与这项双盲研究,该研究经我们机构审查委员会批准。每位受试者随机接受3微克/千克体重的Fe + 0.5毫克氟马西尼,1周后接受3微克/千克体重的Fe + 5毫升0.9%氯化钠溶液(安慰剂)静脉注射。他们保持安静并自主呼吸。使用脉搏血氧仪(SAT、H)和二氧化碳红外吸收监测仪(Oscar,Datex公司)连续测量以下参数:SAT、pCO2和心率(HR)。在5分钟预注射期(基线)前后和操作结束时(25分钟)记录血压。数据存储在微型计算机(Multitalent,ZAK公司)中,并在每次试验后传输到个人电脑。统计学分析。采用Wilcoxon秩和检验对两组进行比较。P值小于0.05具有统计学意义。结果。在试验1和试验2中,pCO2升高,SAT下降。12名受试者(80%)在接受Fe + 氟马西尼后pCO2和SAT的变化更为明显,而1名受试者结果相反。有2名受试者在试验1和试验2之间未显示出差异。与Fe和安慰剂相比,Fe与氟马西尼联合使用导致pCO2显著升高(P = 0.007),SAT显著降低(P = 0.04)。讨论。这些结果表明氟马西尼会轻微增强Fe引起的呼吸抑制。在之前的一项研究中发现,氟马西尼可拮抗Mi的呼吸抑制作用,但基线paCO2并未完全恢复。在之前的研究中,Mi + Fe导致的呼吸功能损害最初可被氟马西尼改善,但观察到对SAT有反跳效应,且比使用安慰剂后更明显。因此,在Mi/Fe麻醉后接受氟马西尼拮抗的患者中,必须密切监测呼吸功能。